MPO与MMP-9和卒中严重程度及结局的关联分析:队列研究
该队列研究纳入255例幕上脑梗死患者,分析血浆MMP-9和MPO浓度与卒中严重程度及3个月结局的关系,并在18例患者中探讨rtPA对外周中性粒细胞脱颗粒的影响。结果显示中性粒细胞计数、NLR和MPO血浆浓度与卒中严重程度正相关,且与更差结局相关,而MMP-9无此关联。
要点
- 中性粒细胞计数、NLR和MPO血浆浓度与卒中严重程度正相关。
- 较高的中性粒细胞计数和NLR独立关联3个月更差结局和更高死亡率。
- 较高的MPO血浆浓度关联更差结局,而MMP-9无此关联。
核心结论
- 中性粒细胞计数、NLR和MPO血浆浓度与急性脑缺血患者更差结局相关,而MMP-9无此关联。
研究设计与样本
- 分析255例症状发作48小时内 recruited 的幕上脑梗死患者数据,不论是否接受rtPA治疗。
- 在18例患者中于4.5小时内和72小时后研究rtPA对外周中性粒细胞脱颗粒的作用。
主要发现
- 中性粒细胞计数、NLR和MPO血浆浓度与卒中严重程度正相关,MMP-9无此相关性。
- 较高的中性粒细胞计数和NLR独立关联3个月更差结局和更高死亡率。
- 较高的MPO血浆浓度关联更差结局,而MMP-9无此关联。
- 体外rtPA刺激后中性粒细胞来源的MMP-9在72小时后更高,但MPO无此变化,且与出血转化无关。
关键数值与推荐
- 终点包括极好结局(改良Rankin量表评分0-1)、症状性颅内出血(欧洲协作急性卒中研究-II定义)和3个月死亡。
临床怎么用
- 中性粒细胞计数、NLR和MPO血浆浓度可作为急性脑缺血患者结局的关联指标,但需进一步研究验证。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In acute cerebral ischemia, circulating neutrophil count and neutrophil-to-lymphocyte ratio (NLR) are positively associated with stroke severity and worse outcomes. Mediators of this effect are unknown. We aimed to investigate (1) the relationship between plasma matrix metalloproteinase-9 (MMP-9) and myeloperoxidase (MPO) concentrations with stroke severity and outcome and (2) MMP-9 and MPO release after ex vivo stimulation of neutrophils by recombinant tissue plasminogen activator (rtPA). METHODS: We analyzed data collected in 255 patients with supratentorial cerebral infarcts recruited within 48 hours of symptoms onset irrespective of rtPA treatment. The endpoints were excellent outcome (modified Rankin Scale score 0-1), symptomatic intracerebral hemorrhage (European Cooperative Acute Stroke Study-II definition), and death at 3 months. The role of rtPA treatment on peripheral neutrophil degranulation was investigated in 18 patients within 4.5 hours and after 72 hours. RESULTS: Neutrophil counts, NLR, and MPO plasma concentrations, but not MMP-9, were positively correlated with stroke severity. Higher neutrophil counts and NLR were independently associated with worse outcomes and higher mortality rates at month 3. Higher MPO plasma concentrations, but not MMP-9, were associated with worse outcome. Neutrophil-derived MMP-9, after ex vivo rtPA stimulation, but not MPO, were higher after 72 hours in patients treated by IV rtPA but not associated with hemorrhagic transformation. CONCLUSIONS: Neutrophil counts, NLR, and MPO plasma concentrations are associated with worse outcome in patients with acute cerebral ischemia, in contrast to MMP-9. Further investigations are needed to deepen our knowledge on MPO's role in the deleterious effect of neutrophils because it could represent a potential therapeutic target.
引用
- Maestrini I, Tagzirt M, Gautier S, et al. Analysis of the association of MPO and MMP-9 with stroke severity and outcome: Cohort study. Neurology. 2020. PMID: 32111692. doi:10.1212/WNL.0000000000009179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。